General Healthcare

Filter

Report Finds UK Children Have the Poorest Health Outcomes in Europe

July 2026

A new report from the Royal College of Paediatrics and Child Health has revealed that children in the UK have some of the worst health outcomes for children in Europe

EMJ

Gilead Announces SVR12 Rates from Phase 3 Study Evaluating Harvoni® for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily…

EMJ

Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)

Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48week results from two Phase 3 studies (Studies 104 and 111)…

EMJ

Hospira Launches First Biosimilar Monoclonal Antibody (mAb) InflectraTM (Infliximab) in Major European Markets

LAKE FOREST, Ill., February 16, 2015 — Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch…

EMJ

New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer…

EMJ

The Outdoors Meets Human Anatomy on New EMJ Covers

The novel creative graphics for our eJournal front pages have stemmed from a desire to make our covers more imaginative and interesting.

EMJ

Basilea Announces That FDA’s Anti-Infective Drugs Advisory Committee Recommends Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis

Basel, Switzerland, January 22, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that the U.S. Food and Drug Administration’s (FDA)…

EMJ

Stem Cells: The Cellular Origins of Fibrosis

POTENTIAL culprits that give rise to chronic tissue scarring, which can lead to the development of fibrosis, have been identified as a rare population of…

EMJ

UEG Puts the Need for Better Care for IBD Patients in Europe on the Political Agenda

(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs…

Loading posts...

« Previous 1 … 63 64 65 66 67 68 Next »